Travaux scientifiques

Doç. Dr. Berkan Armağan

299 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. AB0724 TOFACITINIB DRUG SURVIVAL MAY BE BETTER IN OBESE TNF INHIBITOR RESISTANT RA PATIENTS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.1726 Source : OpenAlex

  2. POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3977 Source : OpenAlex

  3. AB1272 MANAGING OF ANCA-ASSOCIATED VASCULITIS: ADHERENCE TO TREATMENT GUIDELINES AND EARLY MODIFICATIONS, ARE WE THERE YET?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5318 Source : OpenAlex

  4. AB0950 DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3290 Source : OpenAlex

  5. Romatolojide Güncel Tedaviler

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2736 Texte intégral en libre accèsSource : OpenAlex

  6. AB1586-HPR REASONS FOR STOPPING HYDROXYCHLOROQUINE: DO WE GIVE UP EASILY?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.4806 Source : OpenAlex

  7. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

    Clinical and Experimental Rheumatology, 2024

    DOI 10.55563/clinexprheumatol/pzbg88 PMID 41031678 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024

    DOI 10.55730/1300-0144.5872 PMID 39473762 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  9. Treatment patterns of rheumatoid arthritis across different age groups

    Medicine Science | International Medical Journal, 2024

    DOI 10.5455/medscience.2024.02.016 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. A disease to consider in the differential diagnosis of lower back pain: Celiac disease and related autoimmune disorders

    Ankara City Hospital Medical Journal, 2024

    DOI 10.5505/achmedj.2024.02997 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  11. Frailty assessment in patients with Behçet's syndrome: A cross-sectional monocentric study

    Reumatología Clínica (English Edition), 2024

    DOI 10.1016/j.reumae.2024.09.005 PMID 39396353 1 citation (OpenAlex) Source : OpenAlex

  12. OP0175 COMORBIDITIES IN 347.902 RHEUMATOID ARTRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3152 1 citation (OpenAlex) Source : OpenAlex

  13. AB0397 CHARACTERISTICS OF PATIENTS WITH DIFFICULT TO TREAT PSORIATIC ARTHRITIS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3430 1 citation (OpenAlex) Source : OpenAlex

  14. Impact of the long-term hydroxychloroquine use on COVID-19 severity in patients with autoimmune rheumatic disease

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2024

    DOI 10.31067/acusaglik.1344997 Texte intégral en libre accèsSource : OpenAlex

  15. POS1237 PERIPHERAL NERVOUS SYSTEM INVOLVEMENT OF SJÖGREN DISEASE: CHARACTERIZATION AT THE TIME OF DIAGNOSIS IN 16,703 PATIENTS FROM THE SJÖGREN BIG DATA REGISTRY

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3613 Source : OpenAlex

  16. POS1247 CHARACTERIZATION OF 284 PATIENTS PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS OF SJÖGREN DISEASE: RESULTS FROM THE SJÖGREN BIG DATA REGISTRY

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3610 Source : OpenAlex

  17. AB0827 OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3844 Source : OpenAlex

  18. AB0641 DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3297 Source : OpenAlex

  19. Frailty assessment in patients with Behçet's syndrome: A cross-sectional monocentric study

    Reumatología Clínica, 2024

    DOI 10.1016/j.reuma.2024.04.004 Source : OpenAlex

  20. AB0535 ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3305 Source : OpenAlex

  21. AB0394 COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3391 Source : OpenAlex

  22. Age-Related Variations in Treatment Patterns for Axial Spondyloarthritis

    Medical Records, 2024

    DOI 10.37990/medr.1481080 Texte intégral en libre accèsSource : OpenAlex

  23. Glucocorticoids in IgA vasculitis

    Acta Medica, 2024

    DOI 10.32552/2024.actamedica.1100 Texte intégral en libre accèsSource : OpenAlex

  24. AB0777 PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5370 Texte intégral en libre accèsSource : OpenAlex

  25. AB0284 EVALUATION OF THE RELATIONSHIP BETWEEN SERUM NETRIN-1 LEVEL AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.6270 Texte intégral en libre accèsSource : OpenAlex

  26. AB1059 NETRIN-1 IN SPONDYLOARTHRITIS: A NOVEL MARKER TO PREDICT DISEASE ACTIVITY?

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.6349 Texte intégral en libre accèsSource : OpenAlex

  27. EVALUATION OF THE RELATIONSHIP BETWEEN SERUM NETRIN-1 LEVEL AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS

    AYBU AVESIS, 2023

    Source : OpenAlex

  28. Rheumatology experience with FDG PET/CT in inflammation of unknown origin: a single-centre report for determining factors associated with diagnostic precision

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06673-x PMID 37338744 6 citations (Europe PMC) Source : ORCID

  29. AB1553 INVESTIGATION OF FACTORS ASSOCIATED WITH PET/CT EXPERIENCE AND DIAGNOSTIC VALUE IN RHEUMATOLOGY PRACTICE

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.4011 Texte intégral en libre accèsSource : OpenAlex

  30. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

    International journal of rheumatic diseases, 2023

    DOI 10.1111/1756-185x.14490 PMID 36371485 8 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  31. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

    Laboratory medicine, 2023

    DOI 10.1093/labmed/lmad019 PMID 37100766 5 citations (Europe PMC) Source : Europe PMC

  32. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

    Immunopharmacology and immunotoxicology, 2023

    DOI 10.1080/08923973.2022.2160729 PMID 36537308 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  33. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/zr7s0g PMID 37976117 6 citations (OpenAlex) Source : OpenAlex

  34. Tofacitinib experience in patients with enteropathic arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0110 PMID 37009645 5 citations (OpenAlex) Source : OpenAlex

  35. Ustekinumab in Enteropathic Arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0197 PMID 37020400 5 citations (OpenAlex) Source : OpenAlex

  36. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

    Irish Journal of Medical Science (1971 -), 2023

    DOI 10.1007/s11845-023-03519-y PMID 37737913 4 citations (OpenAlex) Source : OpenAlex

  37. COVID ‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14676 PMID 36942871 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  38. Effects of breast milk on Behçet's disease clinical features

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5565 PMID 36945965 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  39. The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

    Iranian Journal of Parasitology, 2023

    DOI 10.18502/ijpa.v18i2.13190 PMID 37583642 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

    Vaccines, 2023

    DOI 10.3390/vaccines11071234 PMID 37515050 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. AB1691 BURDEN OF AFFECTED FACE IN PATIENTS WITH SYSTEMIC SCLEROSIS: A TRANSLATION AND VALIDATION STUDY IN TURKISH

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5553 Texte intégral en libre accèsSource : OpenAlex

  42. AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3450 Texte intégral en libre accèsSource : OpenAlex

  43. Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.59244 Texte intégral en libre accèsSource : OpenAlex

  44. Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür.

    Kocaeli Üniversitesi - AVESİS, 2023

    Source : OpenAlex

  45. Spondiloartropati hastalarında secukinumab ve sertolizumab tedavilerin karşılaştırılması

    AYBU AVESIS, 2023

    Source : OpenAlex

  46. Neurological Involvement in Patients with Primary Sjögren’s Syndrome: A Retrospective Cross-Sectional Study

    Annals of Indian Academy of Neurology, 2023

    DOI 10.4103/aian.aian_138_23 PMID 37970299 10 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  47. AB0638 NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: A RETROSPECTIVE CROSS-SECTIONAL STUDY

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3862 Texte intégral en libre accèsSource : OpenAlex

  48. Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study

    EClinicalMedicine, 2023

    DOI 10.1016/j.eclinm.2023.102062 PMID 37457113 34 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  49. Pulmonary hypertension in Behcet?s disease: echocardiographic screening and multidisciplinary approach

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5617 PMID 37476876 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  50. The impact of antiphospholipid antibodies in Takayasu arteritis

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5573 PMID 36945962 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID